These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33769364)

  • 1. "The lesser of two evils": a framework analysis of consumers' perspectives on opioid deprescribing and the development of opioid deprescribing guidelines.
    Langford AV; Gnjidic D; Lin CC; Bero L; Blyth F; Penm J; Schneider CR
    Pain; 2021 Nov; 162(11):2686-2692. PubMed ID: 33769364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis.
    Langford AV; Gnjidic D; Lin CC; Bero L; Penm J; Blyth FM; Schneider CR
    BMJ Qual Saf; 2021 Feb; 30(2):133-140. PubMed ID: 32220937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers, facilitators, and resources to opioid deprescribing in primary care: experiences of general practitioners in Australia.
    Hamilton M; Mathieson S; Gnjidic D; Jansen J; Weir K; Shaheed CA; Blyth F; Lin CC
    Pain; 2022 Apr; 163(4):e518-e526. PubMed ID: 33990105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations.
    Langford AV; Lin CC; Bero L; Blyth FM; Doctor J; Holliday S; Jeon YH; Moullin J; Murnion B; Nielsen S; Osman R; Penm J; Reeve E; Reid S; Wale J; Schneider CR; Gnjidic D
    Med J Aust; 2023 Jul; 219(2):80-89. PubMed ID: 37356051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework.
    Cross AJ; Buchbinder R; Mathieson S; Bourne A; Maher CG; Lin CC; O'Connor DA
    BMJ Qual Saf; 2022 May; 31(5):387-400. PubMed ID: 35064054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provider beliefs about the ideal design of an opioid deprescribing and substitution intervention for older adults.
    Margraf AM; Davoodi NM; Chen K; Shield RR; McAuliffe LM; Collins CM; Zullo AR
    Am J Health Syst Pharm; 2023 Jan; 80(2):53-60. PubMed ID: 36205419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid deprescribing: Qualitative perspectives from those with chronic non-cancer pain.
    Hamilton M; Gnjidic D; Christine Lin CW; Jansen J; Weir KR; Shaheed CA; Blyth F; Mathieson S
    Res Social Adm Pharm; 2022 Dec; 18(12):4083-4091. PubMed ID: 35963766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
    Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
    Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid deprescribing in patients with chronic noncancer pain: a systematic review of international guidelines.
    Hamilton M; Kwok WS; Hsu A; Mathieson S; Gnjidic D; Deyo R; Ballantyne J; Von Korff M; Blyth F; Lin CC
    Pain; 2023 Mar; 164(3):485-493. PubMed ID: 36001299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.
    Rowe S; Pittman N; Balsom C; Druken R; Kelly DV
    Int J Clin Pharm; 2022 Dec; 44(6):1370-1379. PubMed ID: 36201111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare professionals' perspectives of deprescribing in older patients at the end of life in hospice care: a qualitative study using the Theoretical Domains Framework.
    Alwidyan T; McCorry NK; Parsons C
    Int J Pharm Pract; 2023 May; 31(3):305-313. PubMed ID: 36866441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TANGO: Development of Consumer Information Leaflets to Support TAperiNG of Opioids in Older Adults with Low Back Pain and Hip and Knee Osteoarthritis.
    Marcelo AC; Ho EK; Hunter DJ; Hilmer SN; Jokanovic N; Prior J; Carvalho-E-Silva AP; Ferreira ML
    Drugs Aging; 2023 Apr; 40(4):343-354. PubMed ID: 36972011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary-Care Prescribers' Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults.
    Niznik JD; Ferreri SP; Armistead LT; Kelley CJ; Schlusser C; Hughes T; Henage CB; Busby-Whitehead J; Roberts E
    Drugs Aging; 2022 Sep; 39(9):739-748. PubMed ID: 35896779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study.
    Abou J; Crutzen S; Tromp V; Heringa M; Van Marum R; Elders P; Taxis K; Denig P; Hugtenburg J
    Drugs Aging; 2022 Mar; 39(3):209-221. PubMed ID: 35187614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Provider knowledge, beliefs, and self-efficacy to deprescribe opioids and sedative-hypnotics.
    Gray SL; Fornaro R; Turner J; Boudreau DM; Wellman R; Tannenbaum C; Marcum ZA; Balderson B; Cook A; Jacobsen AL; Phelan EA
    J Am Geriatr Soc; 2023 May; 71(5):1580-1586. PubMed ID: 36546768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers and enablers of older adults initiating a deprescribing conversation.
    Ailabouni NJ; Rebecca Weir K; Reeve E; Turner JT; Wilson Norton J; Gray SL
    Patient Educ Couns; 2022 Mar; 105(3):615-624. PubMed ID: 34183219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist interventions to deprescribe opioids and benzodiazepines in older adults: A rapid review.
    Niznik JD; Collins BJ; Armistead LT; Larson CK; Kelley CJ; Hughes TD; Sanders KA; Carlson R; Ferreri SP
    Res Social Adm Pharm; 2022 Jun; 18(6):2913-2921. PubMed ID: 34281786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of consumer information leaflets for deprescribing in older hospital inpatients: a mixed-methods study.
    Jokanovic N; Aslani P; Carter S; Duong M; Gnjidic D; Jansen J; Le Couteur D; Hilmer S
    BMJ Open; 2019 Dec; 9(12):e033303. PubMed ID: 31831548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives of health professionals towards deprescribing practice in Asian nursing homes: a qualitative interview study.
    Kua CH; Mak VS; Lee SWH
    BMJ Open; 2019 Oct; 9(10):e030106. PubMed ID: 31604786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: protocol for a qualitative evidence synthesis using the Theoretical Domains Framework.
    Cross AJ; Buchbinder R; Bourne A; Maher C; Mathieson S; Lin CC; O'Connor DA
    BMJ Open; 2019 Nov; 9(11):e034039. PubMed ID: 31722956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.